Q3 2022 revenue increases 26% over prior year, with gross margin of 59% BOSTON–(BUSINESS WIRE)–908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today reported financial results for the quarter ended September 30, 2022. “We were pleased with our results for the third quarter … [Read more…]
Rhinostics has partnered with LVL technologies to launch the RHINObot™, a customized version of LVL’s successful decapper instrument that enables both the RHINOstic® and VERIstic™ automated collection devices to offer a complete solution for handsfree sample-in to result-out workflows. The combined solution increases sample throughput while reducing labor requirements, decreasing turnaround times, and bringing consistency, … [Read more…]
Rockwell is restructuring its business in the short-term to drive revenue and expansion opportunities in the growing hemodialysis market and through international pharmaceutical sales By making this strategic shift, Rockwell expects to achieve profitability in 2024, strengthen its overall financial position, and reduce the Company’s reliance on the capital markets to fund future business growth … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Genomics In Cancer Care Market Analysis by Product, by Application, by Technology, End user and by Region – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The genomics in cancer care market size is estimated to be USD 10,354 million in 2021 and is expected to witness a CAGR of … [Read more…]
VANCOUVER, British Columbia–(BUSINESS WIRE)–#mentalhealth–REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO), Revitalist and WAKE Network, Inc. announce the joint venture partnership opening psychedelic clinics and retreats with vertical offerings with a personalized medicine and therapy approach. Revitalist continues to establish its presence as a first full-service psychedelic wellness … [Read more…]
ICR joins University of Cambridge, Imperial College London, UCL and King’s College London as a strategic partner; Apollo continues focus on accessing the world’s best science. CAMBRIDGE, England & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Apollo Therapeutics (‘Apollo’), a portfolio biopharmaceutical company focusing on translational biology and drug development, and The Institute of Cancer Research, London, a world-leading cancer … [Read more…]
Regulatory approval for first patient study of first non-antibiotic macrolide REYKJAVIK, Iceland–(BUSINESS WIRE)–EpiEndo Pharmaceuticals (‘EpiEndo’), the clinical-stage biopharmaceutical company developing therapeutics for chronic inflammatory diseases, has received regulatory approval to commence a Phase 2a clinical trial with lead molecule EP395 in COPD (Chronic Obstructive Pulmonary Disease) patients. EP395 is an orally available macrolide or ‘Barriolide™,’ … [Read more…]
Dexcom Warriors Henry Slade, Roxy Horner, Sheku Kanneh-Mason and Eoin Costelloe unveil their custom Dexcom continuous glucose monitor (CGM) patches to tell their ‘Diabetes Story’ On World Diabetes Day and throughout the month of November, people with diabetes and their support systems are banding together around the globe to help the diabetes community feel more … [Read more…]
RIYADH, Saudi Arabia–(BUSINESS WIRE)–The Middle East’s digital health transformation will be at the top of mind for healthcare and IT leaders at the 2022 HIMSS Middle East Health Conference & Exhibition in mid-November. Healthcare Information and Management Systems Society will convene health professionals in Riyadh, Saudi Arabia, from 19 to 21 November 2022 for world-class … [Read more…]
GENEVA–(BUSINESS WIRE)–#BMD—MEDIMAPS GROUP (www.medimapsgroup.com), a Swiss/Global med-tech company specializing in image processing software for assessing bone health, today announced that its novel method for enhancing osteoporotic fracture risk assessment, Trabecular Bone Score (TBS iNsight™), a surrogate of bone microarchitecture boosted by AI, is now available on diagnostic platforms from OsteoSys Co., Ltd. OsteoSys is the … [Read more…]
